Medication versus surgery for one-sided adrenal hormone problem
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial compares two ways to treat unilateral primary aldosteronism: taking mineralocorticoid receptor antagonist (MRA) pills or having minimally invasive surgery. It may help decide which option works best and is safest for people who can choose surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed one-sided primary aldosteronism (unilateral PA)
- You are between 18 and 70 years old
- Your doctor believes you could safely have surgery
- You have no major reasons you can’t have minimally invasive surgery or take MRA tablets
- You can understand the study information and sign written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a steroid medication (hydrocortisone) after adrenal gland surgery helps protect kidney function in patients with primary aldosteronism and mild-to-moderate kidney disease. Researchers want to see if the steroid reduces further kidney damage.
This study compares two treatments for primary aldosteronism (a condition causing high blood pressure due to an adrenal gland issue). One treatment is a minimally invasive procedure called superselective embolization, and the other is keyhole surgery. This trial aims to see which is better and safer for patients.
This trial tests if measuring a specific steroid can help find which patients with primary aldosteronism (a condition where the adrenal glands make too much of the hormone aldosterone) might be cured by surgery. You would undergo imaging and blood tests from the adrenal veins to see if the problem is in one gland.
This trial tests whether a treatment called SAAE can improve “ventricular remodeling,” meaning changes in the heart muscle, in people with primary aldosteronism (PA). It may help the heart work more efficiently by targeting the cause of high aldosterone levels.
This trial studies whether a procedure called endoscopic ultrasound–guided radiofrequency ablation can treat primary aldosteronism (a hormone condition that can raise blood pressure and potassium issues). It may help shrink an overactive adrenal growth and reduce the need for surgery for some people.
This study compares two treatments for a certain type of adrenal gland tumor (Conn's adenoma) that causes high blood pressure. One is a heat-based procedure called radiofrequency ablation and the other is surgery to remove the tumor. The goal is to see which is better at controlling blood pressure.
Hear when a new Primary Hyperaldosteronism Due to Adrenal Adenoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.